AzTrials
AzTrials

Conductive Hearing LossNCT06535282

Brain Mechanism and Outcome of Surgical Intervention of Conductive Hearing Loss.

A study testing surgery in people with Conductive Hearing Loss and Tinnitus, run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study explores the brain region activation and remodeling of poor connections of brain regions in the postoperative outcomes of conductive hearing loss patients with tinnitus by comparing pre - and post-operative audiological assessment, tinnitus assessment and EEG data. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Conductive Hearing Loss, Tinnitus, Surgery
What is being tested?
surgery
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteChina
Study dates
1 Jan 2018to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • aged between 18 and 60 years;
  • diagnosed with conductive hearing loss with tinnitus;
  • treated with surgery;
  • able to cooperate with all Chinese version evaluation;
  • right-handed.

Who cannot join

  • Pure tone audiometry indicates that the average pure tone hearing threshold (500Hz, 1kHz, 2kHz, 4kHz) is > 91dB HL;
  • acoustic neuroma, nasopharyngeal carcinoma;
  • hearing loss caused by noise or drugs.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Sun Yat-sen Memorial Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, 510000

Other trials in China

About this study

Official title: The Brain Network Mechanism and Outcome After Surgical Intervention of Conductive Hearing Loss Accompanied by Tinnitus.

This study explores the brain region activation and remodeling of poor connections of brain regions in the postoperative outcomes of conductive hearing loss patients with tinnitus by comparing pre - and post-operative audiological assessment, tinnitus assessment and EEG data.

Read the detailed description

This study explores the brain region activation and remodeling of poor connections of brain regions in the postoperative outcomes of conductive hearing loss patients with tinnitus by comparing pre - and post-operative audiological assessment, tinnitus assessment and EEG data. Including audiological assessment (pure tone audiometry, speech test), tinnitus assessment (tinnitus matching, tinnitus handicap inventory, tinnitus function index, visual analogue scale)and non-invasive brain imaging assessment (EEG, fNIRS).

Being tested
surgery
Keywords
Conductive Hearing Loss, tinnitus, surgery, outcome, EEG, mechanism
Medical subject headings
Hearing Loss, Conductive, Tinnitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • surgeryOther

    Surgical treatment of conductive hearing loss with tinnitus

Study groups in NCT06535282
Study groupRoleWhat they receive
baselineNo interventionpre-operative period test results
follow-upOtherpost-operative period test results
Receives: Other: surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pure tone audiometry

    The air- conducted threshold, bone-conducted threshold and air- bone gap of each frequency of pure tone audiometry were used to compare pre - and post-operative hearing level.

    Measured: 3-7 days before surgery, 1-12 months after surgery

  2. speech test

    Speech audiometry was mainly used to analyze the speech recognition rate of patients before and after surgery

    Measured: 3-7 days before surgery, 1-12 months after surgery

  3. EEG activation

    EEG signals were used to explore the activation of brain regions and remodeling of poor connections in the postoperative outcomes of conductive hearing loss patients accompanied by with tinnitus. Power spectral density calculation, traceability analysis, functional connection, microstate, clustering coefficient, feature path length, feature path intermediation, and isocompatibility coefficient were collected and then analyzed.

    Measured: 3-7 days before surgery, 1-12 months after surgery

  4. tinnitus handicap inventory scores

    The total score of the THI scale and the scores of the three subscales(functional, emotional, and catastrophic) were collected before and after surgery for data analysis.

    Measured: 3-7 days before surgery, 1-12 months after surgery

Secondary outcomes (3)
  1. tinnitus function index scores

    The total score of the TFI scale were collected before and after surgery for data analysis.

    Measured: 3-7 days before surgery, 1-12 months after surgery

  2. visual analogue scale

    The total score of the VAS were collected before and after surgery for data analysis. VAS scale 0-10. A score of 0 means that tinnitus has no impact on daily life, and a score of 10 means that tinnitus has an intolerable, fatal level of impact on daily life.

    Measured: 3-7 days before surgery, 1-12 months after surgery

  3. fNIRS activation

    fNIRS signals were used to explore the activation of brain regions and remodeling of poor connections in the postoperative outcomes of conductive hearing loss patients accompanied by with tinnitus. Power spectral density calculation, traceability analysis, functional connection, microstate, clustering coefficient, feature path length, feature path intermediation, and isocompatibility coefficient were collected and then analyzed.

    Measured: 3-7 days before surgery, 1-12 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2024
  2. Study start1 Jan 2018
  3. Primary completion31 Dec 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06535282
Sponsor's protocol ID
SYSKY-2024-328-01
Status last verified
Jul 2024
First submitted
22 May 2024
Last updated
2 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing surgery in people with Conductive Hearing Loss and Tinnitus, run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pure tone audiometry (time frame: 3-7 days before surgery, 1-12 months after surgery). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in